ReviewBMC nephrology2026
Light chain proximal tubulopathy in a 59-year-old woman with Sjögren's syndrome: a case report and review of the literature.
Review in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Light chain proximal tubulopathy (LCPT) is a rare form of monoclonal gammopathy of renal significance (MGRS), characterized by the deposition of monoclonal light chains in proximal renal tubules. We present a case of a 59-year-old female with a 9-year established history of Sjögren’s syndrome (SS) who presented with progressive renal dysfunction. A comprehensive workup revealed a monoclonal IgA-kappa paraproteinemia and a renal biopsy confirmed LCPT. Her diagnosis of SS was re-confirmed with positive anti-SSA/Ro-52 antibodies and focal lymphocytic sialadenitis. The patient exhibited metabolic acidosis, hypophosphatemia, and hypokalemia, consistent with Fanconi syndrome. Notably, her autoimmune condition preceded the development of MGRS by nearly a decade. While this temporal association raises the possibility that chronic immune stimulation in SS could contribute to clonal plasma cell proliferation and subsequent LCPT, such a link remains speculative and cannot be established from a single case. This case highlights the importance of considering MGRS in SS patients with worsening renal tubular dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.